Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke
暂无分享,去创建一个
[1] G. Barnett,et al. Marijuana effect and delta‐9‐tetrahydrocannabinol plasma level , 1984, Clinical pharmacology and therapeutics.
[2] A. P. Mason,et al. Cannabinoids in plasma after passive inhalation of marijuana smoke. , 1983, JAMA.
[3] A. P. Mason,et al. Cannabinoid concentrations in plasma after passive inhalation of marijuana smoke. , 1983, Journal of analytical toxicology.
[4] L. Hollister,et al. Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis. , 1981, Psychopharmacology.
[5] B. Sadler,et al. Metabolism, disposition, and kinetics of delta‐9‐tetrahydrocannabinol in men and women , 1983, Clinical pharmacology and therapeutics.
[6] R. Hawks,et al. The analysis of cannabinoids in biological fluids. , 1982, NIDA research monograph.
[7] A. P. Mason,et al. Ethanol, marijuana, and other drug use in 600 drivers killed in single-vehicle crashes in North Carolina, 1978-1981. , 1984, Journal of forensic sciences.
[8] W. Martin,et al. Methods for evaluating addiction liability. (A) "Attitude" of opiate addicts toward opiate-like drugs. (B) a short-term "direct" addiction test. , 1961, The Journal of pharmacology and experimental therapeutics.
[9] G. Nahas,et al. Marijuana intoxication by passive inhalation: documentation by detection of urinary metabolites. , 1977, The American journal of psychiatry.
[10] C. Cook,et al. Radioimmunoassays for cannabinoids. , 1982, NIDA research monograph.
[11] R. Falck. Passive inhalation of marijuana smoke. , 1983, JAMA.
[12] M. Pérez-Reyes,et al. Comparison of effects of marihuana cigarettes of three different potencies , 1982, Clinical pharmacology and therapeutics.
[13] J. Mendelson,et al. Marijuana consumption and tolerance to physiological and subjective effects. , 1975, Archives of general psychiatry.
[14] C. Haertzen. An Overview of Addiction Research Center Inventory Scales (ARCI): An Appendix and Manual of Scales. , 1974 .
[15] J. Mørland,et al. Cannabinoids in blood and urine after passive inhalation of Cannabis smoke. , 1985, Journal of forensic sciences.
[16] Robert A. Nowlan,et al. Tolerance to marijuana: Heart rate and subjective “high” , 1977, Clinical pharmacology and therapeutics.
[17] E. G. Williams,et al. Studies on marihuana and pyrahexyl compound. , 1946, Public health reports.
[18] L. Hollister,et al. Do plasma concentrations of delta 9-tetrahydrocannabinol reflect the degree of intoxication? , 1981, Journal of clinical pharmacology.
[19] A. Mann,et al. An EMIT assay for cannabinoid metabolites in urine. , 1982, NIDA research monograph.
[20] M. Pérez-Reyes,et al. Passive inhalation of marijuana smoke and urinary excretion cannabinoids. , 1983, JAMA.
[21] L. J. King,et al. Passive inhalation of cannabis smoke , 1984, The Journal of pharmacy and pharmacology.
[22] L. Hollister,et al. Plasma delta‐9‐tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking , 1980, Clinical pharmacology and therapeutics.